Azitra (AZTR) Receivables - Net (2022 - 2026)
Azitra (AZTR) reported Receivables - Net of $5108.0 for Q1 2026, up 460.09% quarter-over-quarter from $912.0 in Q4 2025.
Azitra (AZTR) Receivables - Net (2022 - 2026) Analysis & Trends
Azitra has reported Receivables - Net for 5 years, with the latest figure at $5108.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Net changed N/A year-over-year to $5108.0; the trailing twelve-month figure through Mar 2026 stood at $5108.0 (changed N/A YoY), and the FY2025 full-year result was $912.0, up 291.42% from the prior year.
- Receivables - Net for Q1 2026 stood at $5108.0, up from $912.0 in the prior quarter.
- The five-year high for Receivables - Net was $445120.0 in Q2 2023, with the low at $233.0 in Q4 2024.
- Historically, Receivables - Net has averaged $119395.5 across 5 years, with a median of $47554.0 in 2023.
- Annual changes were most pronounced in 2024 — Receivables - Net plunged 99.74% — and 2025, when it soared 291.42%.
- Azitra's Receivables - Net stood at $175000.0 in 2022, then sank by 48.57% to $90000.0 in 2023, then sank by 99.74% to $233.0 in 2024, then soared by 291.42% to $912.0 in 2025, then surged by 460.09% to $5108.0 in 2026.
- The last three Receivables - Net figures came in at $5108.0 (Q1 2026), $912.0 (Q4 2025), and $233.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,108.00 |
| Mar 31, 2026 | 5,108.00 |
| Dec 31, 2025 | 912.00 |
| Dec 31, 2025 | 912.00 |
| Dec 31, 2024 | 233.00 |
| Dec 31, 2024 | 233.00 |
| Dec 31, 2023 | 90,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Jun 30, 2023 | 445,120.00 |
| Jun 30, 2023 | 445,120.00 |
| Dec 31, 2022 | 175,000.00 |
| Dec 31, 2022 | 175,000.00 |